VELMANASE ALFA

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
19	ライソゾーム病	10

19. ライソゾーム病

臨床試験数 : 899 / 薬物数 : 684 - (DrugBank : 99) / 標的遺伝子数 : 51 - 標的パスウェイ数 : 182

trials per page:

Showing 1 to 10 of 10 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04031066 (ClinicalTrials.gov)	January 11, 2021	17/7/2019	Interventional Study to Assess Efficacy and Safety of Velmanase Alfain Patients With Alpha Mannosido ...	A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evalua ...	Alpha-Mannosidosis	Drug: Velmanase Alfa;Drug: Placebo	Chiesi Farmaceutici S.p.A.	NULL	Withdrawn	N/A	N/A	All	0	Phase 3	NULL
2	EUCTR2016-001988-36-IT (EUCTR)	12/01/2018	05/11/2020	A study, conducted in several sites, with a duration of 2 years to evaluate the Safety and Efficacy ...	A 24-month Multicenter, Open-label Phase II Trial Investigating the Safety and Efficacy of Repeated ...	Alfa-mannosidosis MedDRA version: 20.0;Level: LLT;Classification code 10032658;Term: Other specified ...	Product Name: Velmanase alfa Product Code: [rhLAMAN] INN or Proposed INN: VELMANASE ALFA Other descript ...	CHIESI FARMACEUTICI S.P.A.	NULL	Not Recruiting			Female: yes Male: yes	3	Phase 2	France;Denmark;Austria;Germany;Italy
3	EUCTR2016-001988-36-DE (EUCTR)	09/08/2017	14/02/2017	A study, conducted in several sites, with a duration of 2 years to evaluate the Safety and Efficacy ...	A 24-month Multicenter, Open-label Phase II Trial Investigating the Safety and Efficacy of Repeated ...	Alfa-mannosidosis MedDRA version: 20.0;Level: LLT;Classification code 10032658;Term: Other specified ...	Product Name: Velmanase alfa INN or Proposed INN: VELMANASE ALFA Other descriptive name: recombinant h ...	Chiesi Farmaceutici S.p.A.	NULL	Not Recruiting			Female: yes Male: yes	3	Phase 2	Austria;Denmark;Germany
4	EUCTR2016-001988-36-AT (EUCTR)	10/04/2017	22/02/2017	A study, conducted in several sites, with a duration of 2 years to evaluate the Safety and Efficacy ...	A 24-month Multicenter, Open-label Phase II Trial Investigating the Safety and Efficacy of Repeated ...	Alfa-mannosidosis MedDRA version: 20.0;Level: LLT;Classification code 10032658;Term: Other specified ...	Product Name: Velmanase alfa INN or Proposed INN: VELMANASE ALFA Other descriptive name: recombinant h ...	Chiesi Farmaceutici S.p.A.	NULL	Not Recruiting			Female: yes Male: yes	3	Phase 2	Denmark;Austria;Germany
5	EUCTR2016-001988-36-FR (EUCTR)	27/02/2017	18/09/2020	A study, conducted in several sites, with a duration of 2 years to evaluate the Safety and Efficacy ...	A 24-month Multicenter, Open-label Phase II Trial Investigating the Safety and Efficacy of Repeated ...	Alfa-mannosidosis MedDRA version: 20.0;Level: LLT;Classification code 10032658;Term: Other specified ...	Product Name: Velmanase alfa INN or Proposed INN: VELMANASE ALFA Other descriptive name: recombinant h ...	Chiesi Farmaceutici S.p.A.	NULL	Not Recruiting			Female: yes Male: yes	3	Phase 2	France;Austria;Denmark;Germany;Italy
6	NCT02998879 (ClinicalTrials.gov)	December 2016	25/11/2016	Trial on Safety and Efficacy of Velmanase AlfaTreatment in Pediatric Patients With Alpha-Mannosidosi ...	A 24-month Multicenter, Open-label Phase II Trial Investigating the Safety and Efficacy of Repeated ...	Alpha-Mannosidosis	Drug: Velmanase Alfa (e.g. Lamazym)	Chiesi Farmaceutici S.p.A.	Cromsource	Completed	N/A	6 Years	All	5	Phase 2	Austria;Denmark;France;Germany;Italy
7	EUCTR2016-001988-36-DK (EUCTR)	05/10/2016	11/07/2016	A study, conducted in several sites, with a duration of 2 years to evaluate the Safety and Efficacy ...	A 24-month Multicenter, Open-label Phase II Trial Investigating the Safety and Efficacy of Repeated ...	Alfa-mannosidosis MedDRA version: 20.0;Level: LLT;Classification code 10032658;Term: Other specified ...	Product Name: Velmanase alfa INN or Proposed INN: VELMANASE ALFA Other descriptive name: recombinant h ...	Chiesi Farmaceutici S.p.A.	NULL	Not Recruiting			Female: yes Male: yes	3	Phase 2	Austria;Denmark;Germany;Italy
8	EUCTR2013-000336-97-DK (EUCTR)	30/01/2015	03/12/2014	A trial of the long-term safety of Lamazym aftercare treatment of subjects with alpha-Mannosidosis w ...	A multi-center, un-controlled, open-labeled trial of the long-term safety of Lamazym aftercare treat ...	Alpha-Mannosidosis MedDRA version: 20.0;Level: LLT;Classification code 10032658;Term: Other specifie ...	Product Name: Lamazym Product Code: rhLAMAN INN or Proposed INN: Velmanase alfa Other descriptive name: ...	Chiesi Farmaceutici S.p.A.	NULL	Not Recruiting			Female: yes Male: yes	13	Phase 3	France;Denmark
9	EUCTR2013-000321-31-DK (EUCTR)	07/06/2013	07/06/2013	A long-term safety trial of repeated Velmanase Alfa treatment of subjects with Alpha-Mannosidosis	A multi-center, un-controlled, open-labeled trial of the long-term safety of Velmanase Alfaaftercare ...	Treatement of Alpha-Mannosidosis MedDRA version: 20.0;Level: LLT;Classification code 10032658;Term: ...	Product Name: Velmanase Alfa Product Code: rhLAMAN INN or Proposed INN: velmanase alfa Other descriptiv ...	Chiesi Farmaceutici S.p.A.	NULL	Not Recruiting			Female: yes Male: yes	8	Phase 3	Poland;Denmark
10	EUCTR2013-000321-31-PL (EUCTR)		21/02/2018	A long-term safety trial of repeated Velmanase Alfa treatment of subjects with Alpha-Mannosidosis	A multi-center, un-controlled, open-labeled trial of the long-term safety of Velmanase Alfaaftercare ...	Treatement of Alpha-Mannosidosis MedDRA version: 20.0;Level: LLT;Classification code 10032658;Term: ...	Product Name: Velmanase Alfa Product Code: rhLAMAN INN or Proposed INN: velmanase alfa Other descriptiv ...	Chiesi Farmaceutici S.p.A.	NULL	Not Recruiting			Female: yes Male: yes	5	Phase 3	Poland;Denmark

First Previous1Next Last